Specific Post-Translational Modifications of VDAC3 in ALS-SOD1 Model Cells Identified by High-Resolution Mass

Maria Gaetana Giovanna Pittalà1, Simona Reina2, Stefano Conti Nibali2

  • 1Organic Mass Spectrometry Laboratory, Department of Chemical Sciences, University of Catania, Via S. Sofia 64, 95123 Catania, Italy.

Insights

Oxidative stress in amyotrophic lateral sclerosis (ALS) modifies VDAC3, a mitochondrial protein. These changes, including oxidation and deamidation, may impair its protective function against reactive oxygen species (ROS), impacting ALS progression.

Area of Science:

  • Mitochondrial biology
  • Neuroscience
  • Biochemistry

Background:

  • Oxidative stress is a major factor in motor neuron death in amyotrophic lateral sclerosis (ALS).
  • Mitochondria produce and are damaged by reactive oxygen species (ROS), influencing cellular energy metabolism.
  • Voltage-dependent anion-selective channels (VDACs) in the outer mitochondrial membrane regulate metabolite transport and mitochondrial function.

Purpose of the Study:

  • To investigate if oxidative stress in an ALS cell model induces post-translational modifications (PTMs) in VDAC3.
  • To determine if these PTMs affect VDAC3 functionality and its role in redox signaling.

Main Methods:

  • Utilized an ALS cell model (NSC34 expressing human SOD1G93A) to isolate VDAC-enriched mitochondrial proteins.
  • Employed nano-Ultra-High-Performance Liquid Chromatography/High-Resolution Electrospray Ionization Tandem Mass Spectrometry (nUHPLC/High-Resolution nESI-MS/MS) for protein analysis.

Main Results:

  • Identified specific over-oxidation, deamidation, and succination events in VDAC3 from the ALS cell line.
  • Observed no such modifications in non-ALS cell lines.
  • Demonstrated that deamidation of Asn215 in VDAC3 alters its single-channel behavior in artificial membranes.

Conclusions:

  • Disease-related oxidative stress induces PTMs in VDAC3 in an ALS cellular context.
  • These VDAC3 modifications may compromise its protective role against ROS, potentially contributing to ALS pathogenesis.
  • Findings highlight VDAC3 as a potential target for understanding and treating ALS.

Related Concept Videos